Facebook Twitter Linkedin NASDAQ Market NewsClick here to email authorNEXT STORYPriority Review Granted to BeiGene’s Supplemental New Drug Application in China for Tislelizumab in Urothelial CarcinomaPREV STORYTYME Presents Updated Data at ESMO GI 2019 from TYME-88-Panc Phase II Study Demonstrating Encouraging Overall Survival Trends in Patients with Advanced Pancreatic Cancer